How to Source Etizolam + Escitalopram for Pharmaceutical Formulation
Etizolam + Escitalopram (Tablets, Etizolam(0.25 mg-0.5 mg) + Escitalopram( 5 -10 mg)) is classified under Antipsychotropic Drugs. It is therapeutically aligned with reference brands such as Etizola Plus, Nexito Plus, Stalopam Plus(India & in Asia). This guide highlights key sourcing factors buyers should consider when procuring high-quality Etizolam + Escitalopram for formulation, R&D, or bulk manufacturing.
Product Overview:
Etizolam + Escitalopram tablets are used to treat anxiety with depression. Though not approved in the US/EU, they are popular in Asia. Common strengths include Etizolam 0.5 mg + Escitalopram 10 mg. Ideal for B2B pharma buyers targeting mental health markets with neuropsychiatric product portfolios.
Etizolam + Escitalopram is a fixed-dose combination used in the treatment of anxiety disorders with...
Etizolam + Escitalopram API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Etizolam + Escitalopram must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Etizolam + Escitalopram is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Etizolam + Escitalopram is more than procurement—it’s a strategic partnership. With its tablets form and Etizolam(0.25 mg-0.5 mg) + Escitalopram( 5 -10 mg) specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Etizolam + Escitalopram.
Request a Quote
Frequently Asked Questions For Sourcing of Etizolam + Escitalopram
What is the typical lead time for Etizolam + Escitalopram?
Lead times range from 4–6 weeks depending on supplier and region.
Is Etizolam + Escitalopram available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Etizolam + Escitalopram require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Etizolam + Escitalopram?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Etizolam + Escitalopram?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Etizolam + Escitalopram?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Etizolam + Escitalopram suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Etizolam + Escitalopram be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.